Global Implantable Cardioverter Defibrillator Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product Type;

CRT-D, Regular ICD and S-ICD.

By End-User;

Hospitals and Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn399112820 Published Date: May, 2024 Updated Date: June, 2024

Introduction

Global Implantable Cardioverter Defibrillator Market (USD Million), 2020 - 2030

In the year 2023, the Global Implantable Cardioverter Defibrillator Market was valued at USD 10,665.41 million. The size of this market is expected to increase to USD 14,917.50 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.9%.

The global implantable cardioverter defibrillator (ICD) market encompasses a critical segment of medical devices used in the management of life-threatening cardiac arrhythmias and sudden cardiac arrest. ICDs are sophisticated implantable devices designed to monitor heart rhythm and deliver electrical shocks or pacing therapy when abnormal heart rhythms, such as ventricular tachycardia or ventricular fibrillation, are detected. These devices play a crucial role in preventing sudden cardiac death in patients at high risk of arrhythmias, including those with a history of cardiac arrest, heart failure, or significant arrhythmia episodes. With advancements in technology and device miniaturization, ICDs have become increasingly sophisticated, offering enhanced diagnostic capabilities, longer battery life, and improved patient outcomes.

Key factors driving the growth of the global implantable cardioverter defibrillator market include the increasing prevalence of cardiovascular diseases, rising awareness about sudden cardiac death, and advancements in device technology and implantation techniques. Cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias, represent leading causes of morbidity and mortality worldwide, underscoring the importance of effective cardiac monitoring and intervention strategies. ICDs have emerged as essential tools in the management of high-risk patients, offering continuous cardiac monitoring and prompt intervention to terminate life-threatening arrhythmias and restore normal heart rhythm. Growing awareness about sudden cardiac death and efforts to improve access to defibrillation therapy in public spaces, such as schools, airports, and sports facilities, are driving market growth for implantable cardioverter defibrillators.

North America dominates the global implantable cardioverter defibrillator market, fueled by factors such as the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and favorable reimbursement policies. The region boasts a large number of implantable cardioverter defibrillator manufacturers, research institutions, and healthcare facilities offering comprehensive cardiac care services. Europe follows closely, supported by a growing aging population, increasing adoption of preventive cardiology practices, and advancements in device technology. Emerging economies in the Asia Pacific region, such as China, India, and Japan, are witnessing rapid growth in the implantable cardioverter defibrillator market, driven by improving healthcare infrastructure, rising disposable incomes, and increasing awareness about the benefits of cardiac monitoring and intervention.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Region
  4. Global Implantable Cardioverter Defibrillator Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Cardiovascular Prevalence
        2. Awareness SCD
        3. Technology Advancements
      2. Restraints
        1. Regulatory challenges
        2. Cost constraints
        3. Limited reimbursement
      3. Opportunities
        1. Remote Monitoring
        2. Leadless Technology
        3. MRI Compatibility
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Implantable Cardioverter Defibrillator Market, By Product Type, 2020 - 2030 (USD Million)
      1. CRT-D
      2. Regular ICD
      3. S-ICD
    2. Global Implantable Cardioverter Defibrillator Market, By End-User, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Clinics
    3. Global Implantable Cardioverter Defibrillator Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott
      2. Medtronic
      3. BIOTRONIK SE & Co. KG
      4. Boston Scientific Corporation
      5. MicroPort Scientific Corporation.
      6. LivaNova PLC.
  7. Analyst Views
  8. Future Outlook of the Market